Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas-Reference-Cited by-同舟云学术

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas

Published:2017-12-06 Issue:12 Volume:18 Page:2632
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Tanaka Toshikazu,Yoneyama Tohru,Noro Daisuke,Imanishi Kengo,Kojima Yuta,Hatakeyama Shingo,Tobisawa Yuki,Mori Kazuyuki,Yamamoto Hayato,Imai Atsushi,Yoneyama Takahiro,Hashimoto Yasuhiro,Koie Takuya,Tanaka Masakazu,Nishimura Shin-Ichiro,Kurauchi Shizuka,Takahashi Ippei,Ohyama Chikara

Funder

Japan Society for the Promotion of Science

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/12/2632/pdf

Reference35 articles.

1. Bladder cancer: A disease ripe for major advances;Park;Clin. Adv. Hematol. Oncol.,2014

2. UPPER TRACT UROTHELIAL NEOPLASMS: INCIDENCE AND SURVIVAL DURING THE LAST 2 DECADES

3. Cancer statistics, 2012

4. Carcinoma of the upper urinary tract

5. CT urography for hematuria

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2;International Journal of Clinical Oncology;2024-03-17

2. Impaired bisecting GlcNAc reprogrammed M1 polarization of macrophage;Cell Communication and Signaling;2024-01-26

3. IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy;Biotechnology Advances;2023-10

4. Aberrant protein glycosylation: Implications on diagnosis and Immunotherapy;Biotechnology Advances;2023-09

5. Altered Glycosylation in Progression and Management of Bladder Cancer;Molecules;2023-04-13